tiprankstipranks
Revelation Biosciences (REVB)
NASDAQ:REVB
US Market

Revelation Biosciences (REVB) Income Statement

Compare
159 Followers

Revelation Biosciences Income Statement

Last quarter (Q3 2024), Revelation Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Revelation Biosciences's net income was $-2.24M. See Revelation Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -25.05K$ -40.01K$ -69.17K$ 0.00$ 0.00
Operating Expenses
$ 8.66M$ 10.86M$ 11.95M$ 145.49K$ 3.64K
Depreciation and Amortization
$ 25.05K$ 40.01K$ 69.17K$ 3.80M$ 171.86K
EBITDA
$ -95.21K$ -10.84M$ -11.93M$ -145.49K$ -3.64K
Operating Income
$ -8.66M$ -10.86M$ -11.95M$ -145.49K$ -3.64K
Other Income/Expenses
$ 8.54M$ 34.96K$ -36.35K$ -1.49M$ 2.00
Pretax Income
$ -120.25K$ -10.83M$ -11.99M$ -1.63M$ -3.64K
Net Income
$ -120.25K$ -10.79M$ -11.99M$ -1.63M$ -3.64K
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.53$ -600.77$ -1.28K$ -188.18$ -0.42
Diluted EPS
$ -0.53$ -600.77$ -1.28K$ -188.18$ -0.42
Weighted Average Shares Outstanding
228.00K 17.97K---
Weighted Average Shares Outstanding (Diluted)
228.64K 17.97K---
Currency in USD

Revelation Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis